<?xml version="1.0" encoding="UTF-8"?>
<p>Anti-inflammatory strategies have been investigated. No benefit of corticosteroid therapy on disease severity or length of hospital stay has been demonstrated, despite studies in over a dozen randomized clinical trials of outpatients or hospitalized infants with RSV bronchiolitis. Since the drug is of no benefit on its own [
 <xref ref-type="bibr" rid="CR146">146</xref>] and may prolong virus shedding, it is not recommended. In the future, a possibility might be to combine an effective antiviral treatment with an anti-inflammatory agent [
 <xref ref-type="bibr" rid="CR147">147</xref>].
</p>
